|Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck|
JA Bonner, PM Harari, J Giralt, N Azarnia, DM Shin, RB Cohen, CU Jones, ...
New England Journal of Medicine 354 (6), 567-578, 2006
|Human papillomavirus and survival of patients with oropharyngeal cancer|
KK Ang, J Harris, R Wheeler, R Weber, DI Rosenthal, PF Nguyen-Tân, ...
New England Journal of Medicine 363 (1), 24-35, 2010
|Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash …|
JA Bonner, PM Harari, J Giralt, RB Cohen, CU Jones, RK Sur, D Raben, ...
The lancet oncology 11 (1), 21-28, 2010
|High idiosyncratic volatility and low returns: International and further US evidence|
A Ang, RJ Hodrick, Y Xing, X Zhang
Journal of Financial Economics 91 (1), 1-23, 2009
|A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation …|
KK Fu, TF Pajak, A Trotti, CU Jones, SA Spencer, TL Phillips, AS Garden, ...
International Journal of Radiation Oncology* Biology* Physics 48 (1), 7-16, 2000
|Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma|
KK Ang, BA Berkey, X Tu, HZ Zhang, R Katz, EH Hammond, KK Fu, ...
Cancer research 62 (24), 7350-7356, 2002
|Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (# 22931) and …|
J Bernier, JS Cooper, TF Pajak, M Van Glabbeke, J Bourhis, A Forastiere, ...
Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2005
|Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis|
M Machtay, J Moughan, A Trotti, AS Garden, RS Weber, JS Cooper, ...
Journal of Clinical Oncology 26 (21), 3582, 2008
|Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis|
J Bourhis, J Overgaard, H Audry, KK Ang, M Saunders, J Bernier, ...
The Lancet 368 (9538), 843-854, 2006
|Validation of an accelerated ‘demons’ algorithm for deformable image registration in radiation therapy|
H Wang, L Dong, J O'Daniel, R Mohan, AS Garden, KK Ang, DA Kuban, ...
Physics in Medicine & Biology 50 (12), 2887, 2005
|Radiation response of the central nervous system|
TE Schultheiss, LE Kun, KK Ang, LC Stephens
International Journal of Radiation Oncology* Biology* Physics 31 (5), 1093-1112, 1995
|CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines|
V Grégoire, P Levendag, KK Ang, J Bernier, M Braaksma, V Budach, ...
Radiotherapy and oncology 69 (3), 227-236, 2003
|Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival|
HT Hoffman, K Porter, LH Karnell, JS Cooper, RS Weber, CJ Langer, ...
The Laryngoscope 116 (S111), 1-13, 2006
|Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system|
JL Barker Jr, AS Garden, KK Ang, JC O'Daniel, H Wang, LE Court, ...
International Journal of Radiation Oncology* Biology* Physics 59 (4), 960-970, 2004
|An epithelial–mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor …|
LA Byers, L Diao, J Wang, P Saintigny, L Girard, M Peyton, L Shen, Y Fan, ...
Clinical cancer research 19 (1), 279-290, 2013
|In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody|
L Milas, K Mason, N Hunter, S Petersen, M Yamakawa, K Ang, ...
Clinical cancer research 6 (2), 701-708, 2000
|Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation|
X Huang, L Ding, KL Bennewith, RT Tong, SM Welford, KK Ang, M Story, ...
Molecular cell 35 (6), 856-867, 2009
|Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225|
N Lee, J Harris, AS Garden, W Straube, B Glisson, P Xia, W Bosch, ...
Journal of clinical oncology 27 (22), 3684, 2009
|Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer|
KK Ang, A Trotti, BW Brown, AS Garden, RL Foote, WH Morrison, ...
International Journal of Radiation Oncology* Biology* Physics 51 (3), 571-578, 2001
|Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522|
KK Ang, Q Zhang, DI Rosenthal, PF Nguyen-Tan, EJ Sherman, RS Weber, ...
Journal of clinical oncology 32 (27), 2940, 2014